MD Magazine: Combination Treatment with Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Sofosbuvir in Patients with Genotype 1 HCV Infection

“Optimal retreatment strategies for patients with chronic hepatitis C virus (HCV) infection who have failed treatment with direct-acting antiviral (DAA) regiments are not yet clearly defined,” said Fred Poordad, MD, PhD.

Read the full story at MD Magazine

Share This Article!